Ziopharm Oncology (ZIOP) Prices 27.83M Share Common Offering at $3.25/Sh

Go back to Ziopharm Oncology (ZIOP) Prices 27.83M Share Common Offering at $3.25/Sh

Ziopharm Oncology (ZIOP) Prices 27.826M Share Common Offering at $3.25/Sh

February 7, 2020 5:59 AM EST

Ziopharm Oncology, Inc. (Nasdaq: ZIOP) today announced the pricing of an underwritten public offering of 27,826,086 shares of its common stock at a public offering price of $3.25 per share. Ziopharm has granted the underwriters a 30-day option to purchase up to an additional 4,173,912... More

Ziopharm Oncology (ZIOP) Announces Proposed Common Share Offering

February 7, 2020 5:56 AM EST

Ziopharm Oncology, Inc. (NASDAQ: ZIOP) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Ziopharm. Ziopharm also intends to grant the... More

After-Hours Stock Movers 02/04: (USNA) (MKSI) (PYPL) Higher; (PLT) (KN) (ZIOP) Lower (more...)

February 4, 2020 6:06 PM EST

After-Hours Stock Movers

Plantronics (NYSE: PLT) 30% LOWER; reported Q3 EPS of $0.30, $0.16 better than the analyst estimate of $0.14. Revenue for the quarter came in at $392 million versus the consensus estimate of $400.51 million. Plantronics sees Q4 2020 EPS of ($0.36)-$0.19, versus the consensus of $0.51. Plantronics sees Q4 2020 revenue of $354-394 million, versus the consensus of $441 million.

USANA Health Sciences (NYSE: USNA) 21.2% HIGHER; reported Q4 EPS of $1.41, $0.43 better than the analyst estimate of $0.98. Revenue for the quarter came in at $271.3 million versus the... More

Ziopharm Oncology (ZIOP) to Offer Common Stock

February 4, 2020 4:02 PM EST

Ziopharm Oncology, Inc. (Nasdaq: ZIOP) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Ziopharm. Ziopharm also intends to grant the... More